Alterity Therapeutics (ATHE) Change in Working Capital (2020 - 2024)

Alterity Therapeutics has reported Change in Working Capital for 4 years, with the latest figure at -$7.9 billion in Q2 2024.

• For the quarter ending Q2 2024, Change in Working Capital changed N/A year-over-year to -$7.9 billion; the trailing twelve-month figure through Jun 2024 stood at -$7.9 billion (changed N/A YoY), and the FY2024 full-year result was -$7.9 billion, changed N/A from the prior year.
• Change in Working Capital for Q2 2024 stood at -$7.9 billion, down from $43.7 million in the prior quarter.
• The five-year high for Change in Working Capital was $43.7 million in Q2 2022, with the low at -$7.9 billion in Q2 2024.
• Average Change in Working Capital over 4 years is -$2.2 billion, with a median of -$572.6 million recorded in 2020.
• Year-over-year, Change in Working Capital surged 89.2% in 2021 and jumped 139.13% in 2022.
• Tracing ATHE's Change in Working Capital over 4 years: stood at -$1.0 billion in 2020, then surged by 89.2% to -$111.7 million in 2021, then soared by 139.13% to $43.7 million in 2022, then tumbled by 18101.9% to -$7.9 billion in 2024.
• The last three Change in Working Capital figures came in at -$7.9 billion (Q2 2024), $43.7 million (Q2 2022), and -$111.7 million (Q2 2021), per Business Quant data.

Peer Comparison